TIAA CREF Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$3.11M Sell
32,544
-444
-1% -$42.4K ﹤0.01% 1744
2018
Q4
$2.34M Sell
32,988
-1,466
-4% -$104K ﹤0.01% 1862
2018
Q3
$2.94M Sell
34,454
-2,806
-8% -$240K ﹤0.01% 1928
2018
Q2
$4.32M Sell
37,260
-1,457
-4% -$169K ﹤0.01% 1709
2018
Q1
$3.13M Buy
38,717
+476
+1% +$38.5K ﹤0.01% 1853
2017
Q4
$2.24M Sell
38,241
-2,843
-7% -$167K ﹤0.01% 2074
2017
Q3
$1.92M Sell
41,084
-1,867
-4% -$87.4K ﹤0.01% 2189
2017
Q2
$1.55M Sell
42,951
-382
-0.9% -$13.7K ﹤0.01% 2337
2017
Q1
$1.34M Sell
43,333
-4,258
-9% -$131K ﹤0.01% 2366
2016
Q4
$1.59M Sell
47,591
-15,724
-25% -$527K ﹤0.01% 2309
2016
Q3
$1.69K Sell
63,315
-26,309
-29% -$700 ﹤0.01% 2264
2016
Q2
$1.98M Buy
89,624
+776
+0.9% +$17.1K ﹤0.01% 2134
2016
Q1
$2.61M Buy
88,848
+30,840
+53% +$906K ﹤0.01% 1928
2015
Q4
$1.92M Sell
58,008
-9,589
-14% -$317K ﹤0.01% 2183
2015
Q3
$2.44M Sell
67,597
-1,399
-2% -$50.6K ﹤0.01% 2024
2015
Q2
$3.1M Buy
68,996
+10,905
+19% +$491K ﹤0.01% 2016
2015
Q1
$1.78M Sell
58,091
-788
-1% -$24.1K ﹤0.01% 2290
2014
Q4
$2.99M Sell
58,879
-1,006
-2% -$51.2K ﹤0.01% 1977
2014
Q3
$2.37M Sell
59,885
-14,877
-20% -$589K ﹤0.01% 2116
2014
Q2
$3.22M Buy
74,762
+2,216
+3% +$95.4K ﹤0.01% 1998
2014
Q1
$2.9M Buy
72,546
+36,976
+104% +$1.48M ﹤0.01% 2013
2013
Q4
$970K Buy
35,570
+20,755
+140% +$566K ﹤0.01% 2692
2013
Q3
$340K Buy
14,815
+463
+3% +$10.6K ﹤0.01% 3015
2013
Q2
$254K Buy
+14,352
New +$254K ﹤0.01% 3035